United Kingdom· GB-APID-45486811000001102
Jaypirca 50mg tablets
A pirtobrutinib product containing pirtobrutinib, registered in United Kingdom by Eli Lilly and Company Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Pirtobrutinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01EL05 (pirtobrutinib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Pirtobrutinib · ATC L01EL05
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pirtobrutinib costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.20 in France to $369.10 in Switzerland — a ×1801 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pirtobrutinib · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$369.10
- FR France$0.20
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Pirtobrutinib
- Manufacturer
- Eli Lilly and Company Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01EL05
- ATC class
- Pirtobrutinib
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5014602401344
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pirtobrutinib in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJAYPIRCAEli Lilly Nederland B.V., Utrecht
- SwitzerlandJaypirca
- United StatesJAYPIRCAEli Lilly and Company
- NetherlandsJaypirca 100 mg filmomhulde tablettenEli Lilly Nederland B.V.
- PolandJaypircaEli Lilly Nederland B.V.
- SwedenJaypirca 100 mg Filmdragerad tablettEli Lilly Nederland B.V.
- BelgiumJaypirca 100 mgEli Lilly Nederland
- FinlandJaypircaEli Lilly Nederland B.V
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Jaypirca
- Liechtenstein · Jaypirca
- Norway · Jaypirca
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b9e9281c-47da-4b3e-9786-7a4c37e42b76 GET /v1/drugs/b9e9281c-47da-4b3e-9786-7a4c37e42b76?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45486811000001102",
"desc": "Jaypirca 50mg tablets (Eli Lilly and Company Ltd)",
"form": "Oral tablet",
"vpid": "45489911000001103",
"source": "dmd",
"vtm_id": "45488611000001100",
"strength": "50 mg",
"substance": "Pirtobrutinib",
"ingredient": "Pirtobrutinib",
"supplier_code": "2075101000001100"
}See everything about pirtobrutinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.